Business · 09/09/2019Updated: 10/17/2026 · 1 min read
Eli Lilly and Co., et al.; Withdrawal of FDA Approval for 25 New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 25 new drug applications from various applicants, following written notifications that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →